NAOV

NanoVibronix, Inc. [NAOV] Stock Forecast

Q: What is NanoVibronix, Inc. stock symbol ?

NanoVibronix, Inc. is a US stock, located in Elmsford of Ny and trading under the symbol NAOV

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

NAOV Stock Summary

Earnings have grown 172.07% per last year.

Earnings are expected to fall -100% next year

Does not have any significance market cap ($6M)

NAOV has less than 1 year of cash runway

Top 10 Correlated ETFs

NAOV

Top 10 Correlated Stocks

NAOV

In the News

10:32 26 Mar 2023 NAOV

What Is Going on With NanoVibronix (NAOV) Stock Today?

NanoVibronix (NASDAQ: NAOV ) stock is falling on Tuesday following news of a registered direct offering from the therapeutic ultrasound technology company. This direct offering has NanoVirbronix agreeing to sell 4.8 million shares of NAOV stock to several institutional investors.

11:31 26 Mar 2023 NAOV

Long Term Penny Stocks Investing Strategy (Complete Guide)

Use this guide for investing in penny stocks in the long term The post Long Term Penny Stocks Investing Strategy (Complete Guide) appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

04:05 26 Mar 2023 NAOV

NanoVibronix Sets Date for Annual Shareholder Meeting

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), announced today that its annual meeting of shareholders (the “Annual Meeting”) will take place at 10 a.m. Eastern time on December 15, 2022. The Company will hold the Annual Meeting virtually via the internet. The record date for determination of shareholders entitled to vote at the Annual Meeting is October 17, 2022. The Company anticipates sending proxy materials for the Annual Meeting to stockholders in Nove

03:30 26 Mar 2023 NAOV

Best Penny Stocks to Buy Now? Here's 3 to Watch in April 2022

Can these penny stocks continue to make moves next month? The post Best Penny Stocks to Buy Now?

01:41 26 Mar 2023 NAOV

Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?

Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday and we know why! The post Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?

11:27 26 Mar 2023 NAOV

Health Canada Approves NanoVibronix's PainGuard, UroGuard As Licensed Devices

NanoVibronix Inc's (NASDAQ: NAOV) PainGuard and UroGuard have been approved by Health Canada / Santé Canada as licensed medical devices. The products are offered as private label products through Ideal Medical International Limited.

03:15 26 Mar 2023 NAOV

NanoVibronix, Medina Ink Distribution Pact For Ultrasound Devices In Europe

NanoVibronix Inc (NASDAQ: NAOV) has commenced sales in Europe by signing a distribution agreement with Medina Healthcare Ltd for UroShield and PainShield devices. UroShield is an ultrasound-based product designed to prevent bacterial colonization and biofilm on indwelling urinary catheters and increase antibiotic efficacy, ultimately reducing the incidence of catheter-associated urinary tract infections (CAUTI).

09:06 26 Mar 2023 NAOV

Top Penny Stocks to Know in Mid-October 2021? 3 to Watch

Are these penny stocks on your October watchlist? The post Top Penny Stocks to Know in Mid-October 2021?

10:40 26 Mar 2023 NAOV

NanoVibronix Shares Gain As PainShield Shows Effectiveness In Treating Soft Tissue Pain

NanoVibronix Inc (NASDAQ:NAOV) has announced results from a randomized, double-blind study to evaluate the safety and effectiveness of the NanoVibronix PainShield. Related: NanoVibronix Launches CBD-Based Product For Pain Management.

09:50 26 Mar 2023 NAOV

NAOV Stock: Why It Substantially Increased Today

The stock price of NanoVibronix, Inc., (NASDAQ: NAOV) increased by over 25% during intraday today. This is why it happened.

NAOV Financial details

Company Rating

Neutral

Market Cap

Income

-5.86M

Revenue

1.63M

Book val./share

2.25

Cash/share

1.41

Dividend

Dividend %

Employees

Optionable

Shortable

Yes

Earnings

14 Nov 2022

P/E

-0.87

Forward P/E

PEG

0.18

P/S

3.14

P/B

1.62

P/C

2.59

P/FCF

-0.91

Quick Ratio

Current Ratio

2.91

Debt / Equity

0.65

LT Debt / Equity

EPS (TTM)

-4.32

EPS next Y

EPS next Q

EPS this Y

35.15%

EPS next Y

EPS next 5Y

EPS last 5Y

-10.71%

Revenue last 5Y

47.96%

Revenue Q/Q

-80%

EPS Q/Q

-26.65%

SMA20

-18.33%

SMA50

-39.21%

SMA100

-57.89%

Inst Own

9.4%

Inst Trans

3.54%

ROA

-113%

ROE

-124%

ROC

-1.66%

Gross Margin

44%

Oper. Margin

-357%

Profit Margin

-360%

Payout

Shs Outstand

1.64M

Shs Float

1.39M

Target Price

52W Range

2.94-27.2

52W High

-86.48%

52W Low

+82.5%

RSI

43.25

Rel Volume

0.49

Avg Volume

84.72K

Volume

41.7K

Perf Week

7.04%

Perf Month

-16.67%

Perf Quarter

-60.33%

Perf Half Y

-60.02%

Beta

0.928796

Volatility

0.14%, 0.6%

Prev Close

3.11%

Price

3.65

Change

-3.82%

NAOV Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31
Revenue per share	0.96	0.99	1.53	1.21	1.35
Net income per share	-20	-12.88	-16.7	-8.4	-11.35
Operating cash flow per share	-8.79	-11.01	-11.17	-6.59	-3.47
Free cash flow per share	-8.79	-11.04	-11.17	-6.59	-3.47
Cash per share	17.57	2.78	3.86	13.87	6.15
Book value per share	14.64	1.44	3.89	4.65	5.02
Tangible book value per share	14.64	1.44	3.89	4.65	5.02
Share holders equity per share	14.64	1.44	3.89	4.65	5.02
Interest debt per share	4.97	0.07	0.18	0.35	0
Market cap	23.23M	23.35M	19.78M	7.87M	26.17M
Enterprise value	18.87M	22.45M	18.44M	757.79K	18.48M
P/E ratio	-4.68	-5.62	-3.41	-1.82	-1.83
Price to sales ratio	97.2	73.43	37.32	12.63	15.44
POCF ratio	-10.65	-6.58	-5.11	-2.32	-5.99
PFCF ratio	-10.65	-6.56	-5.11	-2.32	-5.99
P/B Ratio	6.39	50.43	14.67	3.29	4.15
PTB ratio	6.39	50.43	14.67	3.29	4.15
EV to sales	78.96	70.61	34.79	1.22	10.9
Enterprise value over EBITDA	-5.12	-5.28	-3.21	-0.18	-1.29
EV to operating cash flow	-8.65	-6.33	-4.76	-0.22	-4.23
EV to free cash flow	-8.65	-6.31	-4.76	-0.22	-4.23
Earnings yield	-0.21	-0.18	-0.29	-0.55	-0.55
Free cash flow yield	-0.09	-0.15	-0.2	-0.43	-0.17
Debt to equity	0.34	2.41	0.51	2.44	0.37
Debt to assets	0.25	0.71	0.34	0.71	0.27
Net debt to EBITDA	1.18	0.21	0.23	1.71	0.54
Current ratio	5.67	1.92	4.49	2.75	4.38
Interest coverage	-2.5	-195.59	-83.08	-32.1	118.4
Income quality	0.44	0.85	0.67	0.78	0.31
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	8.72	8.29	7.21	6.05	2.98
Research and developement to revenue	2.9	1.93	0.97	0.27	0.17
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	-0.03	0	0	0
Capex to depreciation	0	-1.33	0	-1	-1.5
Stock based compensation to revenue	3.35	2.8	3.31	0.6	0.23
Graham number	81.18	20.4	38.21	29.64	35.8
ROIC	0.77	10.31	6.68	0.76	0.82
Return on tangible assets	-1.02	-2.63	-2.85	-0.53	-1.66
Graham Net	12.87	-0.13	2.33	2.81	4.54
Working capital	3.72M	586K	1.43M	5.07M	6.44M
Tangible asset value	3.63M	463K	1.35M	2.39M	6.31M
Net current asset value	3.29M	109K	1.15M	2.14M	6.03M
Invested capital	0	0	0	0.01	0.01
Average receivables	24.5K	89.5K	137K	111.5K	178.5K
Average payables	125K	180.5K	161K	136.5K	115.5K
Average inventory	71.5K	110K	132.5K	133K	160K
Days sales outstanding	53.45	165.28	89.53	54.49	56.85
Days payables outstanding	696.82	445.85	189.1	128.51	34.33
Days of inventory on hand	315.23	332.66	177.37	129.4	69.05
Receivables turnover	6.83	2.21	4.08	6.7	6.42
Payables turnover	0.52	0.82	1.93	2.84	10.63
Inventory turnover	1.16	1.1	2.06	2.82	5.29
ROE	-1.37	-8.97	-4.3	-1.81	-2.26
Capex per share	0	-0.02	0	0	0

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric	2021-09-30	2021-12-31	2022-03-31	2022-06-30	2022-09-30
Revenue per share	0.38	0.59	0.19	0.35	0.07
Net income per share	-5.12	-1.9	-0.81	-0.93	-0.68
Operating cash flow per share	-0.49	-0.66	-1.24	-1.43	-1.4
Free cash flow per share	-0.49	-0.66	-1.24	-1.43	-1.4
Cash per share	6.59	5.93	4.28	2.82	1.41
Book value per share	6.68	4.84	3.76	2.95	2.25
Tangible book value per share	6.68	4.84	3.76	2.95	2.25
Share holders equity per share	6.68	4.84	3.76	2.95	2.25
Interest debt per share	0	0.02	0.02	0.02	0.03
Market cap	53.76M	27.14M	32.48M	17.64M	12.88M
Enterprise value	45.18M	19.45M	26.53M	13.73M	10.93M
P/E ratio	-2.01	-2.74	-7.17	-3.39	-3.37
Price to sales ratio	107.73	35.02	119.4	36.37	132.77
POCF ratio	-84.79	-31.45	-18.65	-8.82	-6.56
PFCF ratio	-84.66	-31.45	-18.65	-8.81	-6.55
P/B Ratio	6.17	4.3	6.17	4.27	4.08
PTB ratio	6.17	4.3	6.17	4.27	4.08
EV to sales	90.54	25.1	97.54	28.3	112.73
Enterprise value over EBITDA	-6.82	-7.64	-23.31	-10.67	-11.85
EV to operating cash flow	-71.26	-22.54	-15.24	-6.87	-5.57
EV to free cash flow	-71.15	-22.54	-15.24	-6.86	-5.56
Earnings yield	-0.12	-0.09	-0.03	-0.07	-0.07
Free cash flow yield	-0.01	-0.03	-0.05	-0.11	-0.15
Debt to equity	0.11	0.37	0.46	0.58	0.65
Debt to assets	0.1	0.27	0.31	0.37	0.39
Net debt to EBITDA	1.29	3.02	5.22	3.04	2.11
Current ratio	35.43	4.38	3.68	3.07	2.91
Interest coverage	37.74	132.11	85.54	0	-57.75
Income quality	0.09	0.35	1.54	1.54	2.06
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	1.61	3.1	3.46	2.38	7.61
Research and developement to revenue	0.1	0.15	0.24	0.13	0.51
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	-0.02
Capex to depreciation	0	0	0	0	-2
Stock based compensation to revenue	-0.19	0.35	0.32	0.45	-0.2
Graham number	27.72	14.37	8.27	7.86	5.88
ROIC	0.12	0.35	0.25	0.85	-0.77
Return on tangible assets	-0.69	-0.29	-0.15	-0.2	-0.18
Graham Net	6.29	4.38	3.25	2.2	1.28
Working capital	9.16M	6.44M	5.38M	4.26M	3.27M
Tangible asset value	8.71M	6.31M	5.26M	4.13M	3.15M
Net current asset value	8.47M	6.03M	4.99M	3.9M	2.93M
Invested capital	0	0.01	0.01	0.01	0.01
Average receivables	666K	444.5K	654.5K	1.24M	1.45M
Average payables	121.5K	74.5K	129.5K	172.5K	107K
Average inventory	203K	188K	265K	641.5K	1.24M
Days sales outstanding	112.73	30.66	345.77	266.66	1.36K
Days payables outstanding	20.59	15.12	93.25	76.32	217.06
Days of inventory on hand	66.75	30.41	192.47	409.41	8.22K
Receivables turnover	0.8	2.94	0.26	0.34	0.07
Payables turnover	4.37	5.95	0.97	1.18	0.41
Inventory turnover	1.35	2.96	0.47	0.22	0.01
ROE	-0.77	-0.39	-0.22	-0.31	-0.3
Capex per share	0	0	0	0	0

NAOV Frequently Asked Questions

What is NanoVibronix, Inc. stock symbol ?

NanoVibronix, Inc. is a US stock , located in Elmsford of Ny and trading under the symbol NAOV

What is NanoVibronix, Inc. stock quote today ?

NanoVibronix, Inc. stock price is $3.65 today.

Is NanoVibronix, Inc. stock public?

Yes, NanoVibronix, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 84.72K
Market Capitalization 6M
Employee 12
CEO Mr. Brian M. Murphy
Headquarters Elmsford,NY,US
IPO Date 2015-04-24
Website https://www.nanovibronix.com

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.